Clinical and Molecular Profiles of a Cohort of Egyptian Patients with Collagen VI-Related Dystrophy.


Journal

Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991

Informations de publication

Date de publication:
05 Oct 2024
Historique:
received: 30 06 2024
accepted: 11 09 2024
medline: 5 10 2024
pubmed: 5 10 2024
entrez: 4 10 2024
Statut: epublish

Résumé

Collagen VI-related dystrophies (COL6-RD) display a wide spectrum of disease severity and genetic variability ranging from mild Bethlem myopathy (BM) to severe Ullrich congenital muscular dystrophy (UCMD) and the intermediate severities in between with dual modes of inheritance, dominant and recessive. In the current study, next-generation sequencing demonstrated potential variants in the genes coding for the three alpha chains of collagen VI (COL6A1, COL6A2, or COL6A3) in a cohort of Egyptian patients with progressive muscle weakness (n = 23). Based on the age of disease onset and the patient clinical course, subjects were diagnosed as follows: 12 with UCMD, 8 with BM, and 3 with intermediate disease form. Fourteen pathogenic variants, including 5 novel alterations, were reported in the enrolled subjects. They included 3 missense, 3 frameshift, and 6 splicing variants in 4, 3, and 6 families, respectively. In addition, a nonsense variant in a single family and an inframe variant in 3 different families were also detected. Recessive and dominant modes of inheritance were recorded in 9 and 8 families, respectively. According to ACMG guidelines, variants were classified as pathogenic (n = 7), likely pathogenic (n = 4), or VUS (n = 3) with significant pathogenic potential. To our knowledge, the study provided the first report of the clinical and genetic findings of a cohort of Egyptian patients with collagen VI deficiency. Inter- and intra-familial clinical variability was evident among the study cohort.

Identifiants

pubmed: 39367186
doi: 10.1007/s12031-024-02266-8
pii: 10.1007/s12031-024-02266-8
doi:

Substances chimiques

Collagen Type VI 0
Col6a1 protein, human 0
COL6A3 protein, human 0
COL6A2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93

Subventions

Organisme : NRC
ID : 12060178
Organisme : NRC
ID : 12060178
Organisme : NRC
ID : 12060178
Organisme : STDF
ID : 33650
Organisme : STDF
ID : 33650
Organisme : STDF
ID : 33650
Organisme : STDF
ID : 33650
Organisme : STDF
ID : 33650
Organisme : STDF
ID : 33650

Informations de copyright

© 2024. The Author(s).

Références

Ahmed SM (2017) Consanguineous marriage among Egyptian youth: secondary analysis of survey of young people in Egypt, 2014. Egypt J Commun Med 35(2):85–94. https://doi.org/10.21608/ejcm.2017.3571
doi: 10.21608/ejcm.2017.3571
Allamand V, Merlini L, Bushby K (2010) 166th ENMC International workshop on collagen type VI-related myopathies, 22–24 May 2009, Naarden, The Netherlands. Neuromuscul Disord 20(5):346–354. https://doi.org/10.1016/j.nmd.2010.02.012
doi: 10.1016/j.nmd.2010.02.012
Bardakov SN, Deev RV, Magomedova RM, Umakhanova ZR, Allamand V, Gartioux C, Zulfugarov KZ, Akhmedova PG, Tsargush VA, Titova AA, Mavlikeev MO, Zorin VL, Chernets EN, Dalgatov GD, Konovalov FA, Isaev AA (2021) Intrafamilial phenotypic variability of collagen VI-related myopathy due to a new mutation in the COL6A1 gene. J Neuromuscul Dis 8(2):273–285. https://doi.org/10.3233/jnd-200476
doi: 10.3233/jnd-200476 pmcid: 8075389
Bönnemann CG (2011) The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol 7(7):379–390. https://doi.org/10.1038/nrneurol.2011.81
doi: 10.1038/nrneurol.2011.81 pmcid: 5210181
Bönnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, Muntoni F, Sewry C, Béroud C, Mathews KD, Moore SA, Bellini J, Rutkowski A, North KN (2014) Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 24(4):289–311. https://doi.org/10.1016/j.nmd.2013.12.011
doi: 10.1016/j.nmd.2013.12.011 pmcid: 5258110
Bozorgmehr B, Kariminejad A, Nafissi S, Jebelli B, Andoni U, Gartioux C, Ledeuil C, Allamand V, Richard P, Kariminejad MH (2013) Ullrich congenital muscular dystrophy (UCMD): clinical and genetic correlations. Iran J Child Neurol 7(3):15–22
pmcid: 3943075
Briñas L, Richard P, Quijano-Roy S, Gartioux C, Ledeuil C, Lacène E, Makri S, Ferreiro A, Maugenre S, Topaloglu H, Haliloglu G, Pénisson-Besnier I, Jeannet P-Y, Merlini L, Navarro C, Toutain A, Chaigne D, Desguerre I, de Die-Smulders C, Dunand M, Echenne B, Eymard B, Kuntzer T, Maincent K, Mayer M, Plessis G, Rivier F, Roelens F, Stojkovic T, Taratuto AL, Lubieniecki F, Monges S, Tranchant C, Viollet L, Romero NB, Estournet B, Guicheney P, Allamand V (2010) Early onset collagen VI myopathies: genetic and clinical correlations. Ann Neurol 68(4):511–520. https://doi.org/10.1002/ana.22087
doi: 10.1002/ana.22087
Butterfield RJ, Foley AR, Dastgir J, Asman S, Dunn DM, Zou Y, Hu Y, Donkervoort S, Flanigan KM, Swoboda KJ, Winder TL, Weiss RB, Bönnemann CG (2013) Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathies. Hum Mutat 34(11):1558–1567. https://doi.org/10.1002/humu.22429
doi: 10.1002/humu.22429 pmcid: 4520221
Choi Y, Chan AP (2015) PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31(16):2745–2747. https://doi.org/10.1093/bioinformatics/btv195
doi: 10.1093/bioinformatics/btv195 pmcid: 4528627
Cruz S, Figueroa-Bonaparte S, Gallardo E, de Becdelievre A, Gartioux C, Allamand V, Piñol P, Garcia MAR, Jiménez-Mallebriera C, Llauger J, González-Rodríguez L, Cortes-Vicente E, Illa I, Díaz-Manera J (2016) Bethlem myopathy phenotypes and follow up: description of 8 patients at the mildest end of the spectrum. J Neuromuscul Dis 3:267–274. https://doi.org/10.3233/JND-150135
doi: 10.3233/JND-150135
Foley AR, Hu Y, Zou Y, Yang M, Medne L, Leach M, Conlin LK, Spinner N, Shaikh TH, Falk M, Neumeyer AM, Bliss L, Tseng BS, Winder TL, Bönnemann CG (2011) Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. Ann Neurol 69(1):206–211. https://doi.org/10.1002/ana.22283
doi: 10.1002/ana.22283 pmcid: 5154621
Inoue M, Saito Y, Yonekawa T, Ogawa M, Iida A, Nishino I, Noguchi S (2021) Causative variant profile of collagen VI-related dystrophy in Japan. Orphanet J Rare Dis 16(1):284. https://doi.org/10.1186/s13023-021-01921-2
doi: 10.1186/s13023-021-01921-2 pmcid: 8223365
Kwong AK, Zhang Y, Ho RS, Gao Y, Ling X, Tsang MH, Luk HM, Chung BH, Bönnemann CG, Javed A, Chan SH (2023) Collagen VI-related myopathies: clinical variability, phenotype-genotype correlation and exploratory transcriptome study. Neuromuscul Disord 33(5):371–381. https://doi.org/10.1016/j.nmd.2023.03.003
doi: 10.1016/j.nmd.2023.03.003
Lamandé SR, Bateman JF (2018) Collagen VI disorders: insights on form and function in the extracellular matrix and beyond. Matrix Biol 71–72:348–367. https://doi.org/10.1016/j.matbio.2017.12.008
doi: 10.1016/j.matbio.2017.12.008
Lampe AK, Zou Y, Sudano D, O’Brien KK, Hicks D, Laval SH, Charlton R, Jimenez-Mallebrera C, Zhang R-Z, Finkel RS, Tennekoon G, Schreiber G, van der Knaap MS, Marks H, Straub V, Flanigan KM, Chu M-L, Muntoni F, Bushby KMD, Bönnemann CG (2008) Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. Hum Mutat 29(6):809–822. https://doi.org/10.1002/humu.20704
doi: 10.1002/humu.20704
Lee JH, Shin HY, Park HJ, Kim SH, Kim SM, Choi YC (2017) Clinical, pathologic, and genetic features of collagen VI-related myopathy in Korea. J Clin Neurol 13(4):331–339. https://doi.org/10.3988/jcn.2017.13.4.331
doi: 10.3988/jcn.2017.13.4.331 pmcid: 5653620
Li C, Zhi D, Wang K, Liu X (2022) MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning. Genome Med 14(1):115. https://doi.org/10.1186/s13073-022-01120-z
doi: 10.1186/s13073-022-01120-z pmcid: 9548151
Marinella G, Astrea G, Buchignani B, Cassandrini D, Doccini S, Filosto M, Galatolo D, Gallone S, Giannini F, Lopergolo D, Maioli MA, Magri F, Malandrini A, Mandich P, Mari F, Massa R, Mata S, Melani F, Moggio M, Mongini TE, Pasquariello R, Pegoraro E, Ricci F, Ricci G, Rodolico C, Rubegni A, Siciliano G, Sperti M, Ticci C, Tonin P, Santorelli FM, Battini R (2022) A schematic approach to defining the prevalence of COL VI variants in five years of next-generation sequencing. Int J Mol Sci 23(23):14567. https://doi.org/10.3390/ijms232314567
doi: 10.3390/ijms232314567 pmcid: 9735635
Di Martino A, Cescon M, D’Agostino C, Schilardi F, Sabatelli P, Merlini L, Faldini C (2023) Collagen VI in the musculoskeletal system. Int J Mol Sci 24(6). https://doi.org/10.3390/ijms24065095
Morel V, Audic F, Tardy C, Verschueren A, Attarian S, Nguyen K, Salort-Campana E, Krahn M, Chabrol B, Gorokhova S (2023) Retrospective clinical and genetic analysis of COL6-RD patients with a long-term follow-up at a single French center. Front Genet 14:1242277. https://doi.org/10.3389/fgene.2023.1242277
doi: 10.3389/fgene.2023.1242277 pmcid: 10753780
Natera-de Benito D, Foley AR, Domínguez-González C, Ortez C, Jain M, Mebrahtu A, Donkervoort S, Hu Y, Fink M, Yun P, Ogata T, Medina J, Vigo M, Meilleur KG, Leach ME, Dastgir J, Díaz-Manera J, Carrera-García L, Jessica Expósito-Escudero J, Alarcon M, Cuadras D, Montiel-Morillo E, Milisenda JC, Dominguez-Rubio R, Olivé M, Colomer J, Jou C, Jimenez-Mallebrera C, Bönnemann CG, Nascimento A (2021) Association of initial maximal motor ability with long-term functional outcome in patients with COL6-related dystrophies. Neurology 96(10):e1413–e1424. https://doi.org/10.1212/wnl.0000000000011499
doi: 10.1212/wnl.0000000000011499 pmcid: 8055317
Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132(Pt 11):3175–3186. https://doi.org/10.1093/brain/awp236
doi: 10.1093/brain/awp236
Picillo E, Torella A, Passamano L, Nigro V, Politano L (2022) Autosomal dominant Ullrich congenital muscular dystrophy due to a de novo mutation in COL6A3 gene. A case report. Acta Myol 41(2):95–98. https://doi.org/10.36185/2532-1900-073
doi: 10.36185/2532-1900-073 pmcid: 9237747
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
doi: 10.1038/gim.2015.30 pmcid: 4544753
Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361–362. https://doi.org/10.1038/nmeth.2890
doi: 10.1038/nmeth.2890
Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133(1):1–9. https://doi.org/10.1007/s00439-013-1358-4
doi: 10.1007/s00439-013-1358-4
Topaloğlu H, Poorshiri B (2024) The congenital muscular dystrophies. Ann Child Neurol Soc 2(1):27–39. https://doi.org/10.1002/cns3.20050
doi: 10.1002/cns3.20050
Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G (2010) Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics 11:548. https://doi.org/10.1186/1471-2105-11-548
doi: 10.1186/1471-2105-11-548 pmcid: 2992548
Williams L, Layton T, Yang N, Feldmann M, Nanchahal J (2022) Collagen VI as a driver and disease biomarker in human fibrosis. FEBS J 289(13):3603–3629. https://doi.org/10.1111/febs.16039
doi: 10.1111/febs.16039
Yonekawa T, Nishino I (2014) Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s). J Neurol Neurosurg Psychiatr 86. https://doi.org/10.1136/jnnp-2013-307052

Auteurs

Wessam E Sharaf-Eldin (WE)

Medical Molecular Genetics, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Karima Rafat (K)

Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, 12311, Egypt.

Mahmoud Y Issa (MY)

Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, 12311, Egypt.

Hasnaa M Elbendary (HM)

Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, 12311, Egypt.

Noura R Eissa (NR)

Medical Molecular Genetics, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Bahaa Hawaary (B)

Pediatrics Department, Faculty of Medicine, Aswan University, Aswan, Egypt.

Nagwa E A Gaboon (NEA)

Medical Genetics Centre, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Medical Genetics Department, Armed Forces College of Medicine, Cairo, Egypt.

Reza Maroofian (R)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.

Joseph G Gleeson (JG)

Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093, USA.
Rady Children's Institute for Genomic Medicine, San Diego, La Jolla, CA, 92093, USA.

Mona L Essawi (ML)

Medical Molecular Genetics, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Maha S Zaki (MS)

Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, 12311, Egypt. dr_mahazaki@yahoo.com.
Medical Genetics Department, Armed Forces College of Medicine, Cairo, Egypt. dr_mahazaki@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH